Prim (XMAD:PRM) Loans Receivable: €0.0 Mil (As of Dec. 2025)


XMAD:PRM Prim SA XMAD:PRM
76 GF Score
Price €13.40
GF Value €7.60
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Prim Loans Receivable?

Prim XMAD:PRM +0.75% 76 Loans Receivable is €0.0 Mil as of Dec. 2025. GuruFocus rates XMAD:PRM with a GF Score™ of 76/100 and a GF Value™ of €7.60 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Prim's Loans Receivable for the quarter that ended in Dec. 2025 was €0.0 Mil.

Prim Loans Receivable Historical Data

* Premium members only.

The historical data trend for Prim's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prim Loans Receivable Chart

Prim Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Prim Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XMAD:PRM
76GF Score
Prim SA XMAD:PRM
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Prim Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of €0.0 Mil mean?
Prim (XMAD:PRM) has a Loans Receivable of €0.0 Mil as of Dec. 2025. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Prim and its competitors.
Is Prim's Loans Receivable too high?
Prim's current Loans Receivable is €0.0 Mil. Overall, Prim has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Prim's Loans Receivable compare to ISRG and BDX?
Prim's Loans Receivable of €0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Medical Devices & Instruments company?
A good Loans Receivable depends on the Medical Devices & Instruments industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Prim and its competitors. Prim's current Loans Receivable is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prim stock overvalued right now?
Based on GuruFocus' analysis, Prim (XMAD:PRM) is currently considered Significantly Overvalued. The stock's GF Value™ is €7.60, compared to a current price of €13.40 — trading 76.3% above its estimated fair value. The current Loans Receivable is €0.0 Mil. Prim's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Prim (XMAD:PRM), the current Loans Receivable is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Prim (XMAD:PRM) Overvalued in 2026?

Based on GuruFocus' analysis, Prim stock appears to be overvalued. The current stock price of €13.40 is trading 76.3% above its estimated GF Value™ of €7.60. GuruFocus considers Prim to be Significantly Overvalued.

Key valuation signals for XMAD:PRM:

  • Loans Receivable: €0.0 Mil
  • GF Value™: €7.60 vs. price of €13.40 (76.3% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the XMAD:PRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prim Business Description

Other Exchanges 0FP0:UK5P1:Germany
Address Calle F, numero 15, Poligono Industrial 1, Mostoles, Madrid, ESP, 28938
Prim SA is engaged in the provision of hospital supplies. The company is in a hospital and orthopedic supplies and materials for physiotherapy, thalassotherapy, thermal therapy, rehabilitation, geriatrics, as well as daily living aids. Prim work across a division of healthcare units such as Operating Theatres; Pain Management Centres; Plastic Surgery; Endosurgery and Cardiovascular.
76GF Score

Get the complete analysis for XMAD:PRM

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.40
Price
€7.60
GF Value